STAT News

STAT+: Regeneron drug for disease that causes dangerous bone growth earns FDA approval

A Regeneron drug that treats an ultra-rare disease that causes bone to form where it's not meant to be has won approval.

Por STAT News

1 minuto de lectura
Compartir
STAT+: Regeneron drug for disease that causes dangerous bone growth earns FDA approval
STAT+: Regeneron drug for disease that causes dangerous bone growth earns FDA approval

¿Tiene noticias que compartir con el sector de eventos?

Envíe un comunicado de prensa o una noticia y llegue a miles de profesionales del sector de eventos.

Contáctenos→

Más en Health Tech

Perspectivas relacionadas